牛叉诊股

[{"date":"2025.04.03","stock":"-0.11","trade":"-0.37","ind":"-1.40"},{"date":"2025.04.02","stock":"-1.05","trade":"-0.51","ind":"0.09"},{"date":"2025.04.01","stock":"2.42","trade":"4.49","ind":"-0.01"},{"date":"2025.03.31","stock":"-1.18","trade":"-1.36","ind":"-0.97"},{"date":"2025.03.28","stock":"0.22","trade":"0.82","ind":"-0.57"},{"date":"2025.03.27","stock":"0.26","trade":"1.99","ind":"0.23"},{"date":"2025.03.26","stock":"-0.37","trade":"0.15","ind":"-0.05"},{"date":"2025.03.25","stock":"0.82","trade":"0.61","ind":"-0.43"},{"date":"2025.03.24","stock":"-2.07","trade":"-0.79","ind":"0.07"},{"date":"2025.03.21","stock":"-1.68","trade":"-1.77","ind":"-1.76"},{"date":"2025.03.20","stock":"-0.32","trade":"-0.89","ind":"-0.91"},{"date":"2025.03.19","stock":"-2.60","trade":"-0.16","ind":"-0.32"},{"date":"2025.03.18","stock":"0.42","trade":"0.78","ind":"0.52"},{"date":"2025.03.17","stock":"0.63","trade":"0.96","ind":"-0.19"},{"date":"2025.03.14","stock":"1.13","trade":"1.98","ind":"2.26"},{"date":"2025.03.13","stock":"1.40","trade":"-0.67","ind":"-0.99"},{"date":"2025.03.12","stock":"-0.32","trade":"-1.15","ind":"-0.17"},{"date":"2025.03.11","stock":"0.36","trade":"-0.37","ind":"0.33"},{"date":"2025.03.10","stock":"0.14","trade":"0.90","ind":"-0.17"},{"date":"2025.03.07","stock":"-1.28","trade":"-1.03","ind":"-0.50"},{"date":"2025.03.06","stock":"1.15","trade":"1.90","ind":"1.77"}]

博雅生物,深证成指,生物制品指数

压力支撑

该股压力位为27.17元，支撑位为26.98元。

[{"text":"\u538b\u529b\u4f4d","value":"27.17","date":1743609600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"26.98","date":1743609600,"color":"0x0b52a1"}]

多空趋势

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：3.8资金面打败了43%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力筹码较分散，呈低度控盘状态。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

生物制品行业，近5日资金总体无进出。

更新时间：04月04日 20:34

机构今日流向(万元)	-562.36	机构5日流向(万元)	1211.39
机构10日流向(万元)	-801.62	机构20日流向(万元)	-2838.21

机构持仓

2024-12-31 与 2024-06-30 相比，主力机构持仓量增加6071.74万股，其中基金净增仓9家，主力净减仓44家，请投资者中长期谨慎为宜。

截止2024-12-31，共156家主力机构（基金152家，一般法人4家），持仓量总计29559.98万股，占流通A股58.62%
其中，基金持仓与2024-06-30相比：
增仓：46家，增持 601.03万股
减仓：37家，减持 1652.22万股
新出现在主力名单中：53家，持有853.25万股
从主力名单中消失：97家，原持有2227.16万股

消息面诊股

诊断结果：7消息面打败了94%的股票今日有利好新闻的公司

近期该股利好消息较多，投资者可加强关注。

消息面得分最高的股票

消息列表

一般消息	股东大会	年度股东大会	2025-03-19
利好	分红转增	10派1.60元(含税)	2025-03-19
一般消息	重大事项	关联交易	2025-03-19
一般消息	募资投向		2025-03-18
一般消息	高管变动	因工作调动原因	2025-03-06
重大利好	业绩预告	业绩大幅上升	2025-01-22
一般消息	高管变动	因工作调动原因	2024-10-21
一般消息	高管变动	因个人原因	2024-09-27
一般消息	高管变动	工作调动原因	2024-09-10
利好	分红转增	10派1.60元(含税)	2024-08-24
一般消息	高管变动	委员会调整	2024-07-16

一年消息统计

	所有消息	重大消息	非重大消息
利好	3条	1条	2条
利空	0条	0条	0条

行业面诊股

诊断结果：7.4行业面打败了97%的股票生物制品行业最新资金流向

近10日来该行业走势不明显，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，跑赢大盘。

[{"date":"2025.04.03","price":"-1.40","value":"-0.37"},{"date":"2025.04.02","price":"0.09","value":"-0.51"},{"date":"2025.04.01","price":"-0.01","value":"4.49"},{"date":"2025.03.31","price":"-0.97","value":"-1.36"},{"date":"2025.03.28","price":"-0.57","value":"0.82"},{"date":"2025.03.27","price":"0.23","value":"1.99"},{"date":"2025.03.26","price":"-0.05","value":"0.15"},{"date":"2025.03.25","price":"-0.43","value":"0.61"},{"date":"2025.03.24","price":"0.07","value":"-0.79"},{"date":"2025.03.21","price":"-1.76","value":"-1.77"},{"date":"2025.03.20","price":"-0.91","value":"-0.89"},{"date":"2025.03.19","price":"-0.32","value":"-0.16"},{"date":"2025.03.18","price":"0.52","value":"0.78"},{"date":"2025.03.17","price":"-0.19","value":"0.96"},{"date":"2025.03.14","price":"2.26","value":"1.98"},{"date":"2025.03.13","price":"-0.99","value":"-0.67"},{"date":"2025.03.12","price":"-0.17","value":"-1.15"},{"date":"2025.03.11","price":"0.33","value":"-0.37"},{"date":"2025.03.10","price":"-0.17","value":"0.90"},{"date":"2025.03.07","price":"-0.50","value":"-1.03"},{"date":"2025.03.06","price":"1.77","value":"1.90"}]

深证成指,生物制品行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	康弘药业	36.10%	9.76%	5.0分
2	荣昌生物	31.35%	10.00%	5.2分
3	科兴制药	27.81%	9.56%	6.0分
4	迈威生物	23.37%	18.77%	5.4分
5	赛升药业	20.80%	17.72%	4.3分
6	智翔金泰	19.00%	2.15%	4.8分
7	康华生物	16.58%	0.49%	5.0分
8	康辰药业	14.47%	15.64%	5.8分
9	凯因科技	13.91%	8.30%	5.6分
10	昊帆生物	12.51%	3.74%	4.7分
11	艾迪药业	10.00%	11.09%	5.0分
12	西藏药业	9.91%	0.68%	5.3分
13	百奥泰	7.65%	12.46%	5.5分
14	诺唯赞	7.19%	1.66%	5.2分
15	长春高新	5.15%	2.92%	5.2分
16	君实生物	4.48%	5.63%	5.6分
17	派林生物	4.23%	0.09%	5.2分
18	卫光生物	4.21%	0.84%	5.3分
19	天坛生物	4.07%	1.52%	5.8分
20	上海莱士	3.21%	2.16%	5.7分
21	通化东宝	2.77%	0.78%	5.0分
22	百克生物	1.91%	5.76%	5.7分
23	华兰生物	1.56%	1.06%	5.4分
24	我武生物	1.50%	5.66%	4.7分
25	义翘神州	1.04%	0.44%	4.2分
26	甘李药业	0.94%	1.54%	6.2分
27	神州细胞	0.43%	4.28%	5.6分
28	三生国健	0.18%	0.51%	4.9分
29	欧林生物	0.06%	8.16%	5.5分
30	东宝生物	-0.18%	-0.72%	4.3分
31	康泰生物	-0.57%	-0.32%	4.4分
32	安科生物	-0.68%	-1.91%	4.8分
33	优宁维	-0.79%	1.17%	4.3分
34	智飞生物	-1.14%	0.84%	4.8分
35	成大生物	-1.43%	1.40%	5.3分
36	诺诚健华	-1.70%	3.70%	4.6分
37	赛伦生物	-1.75%	1.70%	4.5分
38	辽宁成大	-2.66%	-1.30%	4.5分
39	博晖创新	-2.86%	0.87%	4.5分
40	特宝生物	-2.98%	-2.82%	5.3分
41	华兰疫苗	-3.01%	-1.19%	4.5分
42	万泽股份	-3.08%	-2.28%	4.7分
43	博雅生物	-3.27%	0.26%	5.1分
44	金迪克	-3.43%	2.81%	3.0分
45	万泰生物	-3.87%	-1.28%	4.5分
46	沃森生物	-4.45%	0.26%	4.2分
47	近岸蛋白	-5.82%	-2.76%	3.5分
48	康希诺	-6.03%	2.99%	4.8分
49	未名医药	-9.10%	-7.17%	4.2分
50	-	-14.94%	-0.12%	分
51	百普赛斯	-15.81%	-9.06%	4.2分
52	双成药业	-39.24%	-7.10%	3.7分
53	四环生物	-	11.59%	5.1分

<上一页 1 2 3 4 5...9 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：6.1基本面打败了60%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，多数机构认为该股长期投资价值较高，投资者可加强关注。

个股深一度

潜在高分红能力：弱（77.5分）

基本面得分最高的股票

[ 截止日期：2024-12-31 ]公司经营

盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 8/73 ， 14/73。

[{"date":"2024-12-31","value":"5.36","vol":"0.49"},{"date":"2024-09-30","value":"5.54","vol":"1.38"},{"date":"2024-06-30","value":"4.27","vol":"0.75"},{"date":"2024-03-31","value":"2.06","vol":"0.43"},{"date":"2023-12-31","value":"3.27","vol":"1.90"}]

	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31
净资产收益率(%)	5.36	5.54	4.27	2.06	3.27
行业(%)	0.49	1.38	0.75	0.43	1.90

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2024-12-31","value":"64.65","vol":"77.77"},{"date":"2024-09-30","value":"66.67","vol":"70.59"},{"date":"2024-06-30","value":"67.03","vol":"69.95"},{"date":"2024-03-31","value":"67.79","vol":"70.47"},{"date":"2023-12-31","value":"52.76","vol":"69.93"}]

	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31
销售毛利率(%)	64.65	66.67	67.03	67.79	52.76
行业(%)	77.77	70.59	69.95	70.47	69.93

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 15/73 ， 3/73。

[{"date":"2024-12-31","value":"-34.58","vol":"17.17"},{"date":"2024-09-30","value":"-43.16","vol":"173.83"},{"date":"2024-06-30","value":"-41.87","vol":"18.08"},{"date":"2024-03-31","value":"-44.36","vol":"29.63"},{"date":"2023-12-31","value":"-3.87","vol":"18.84"}]

	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31
营业收入同比增长率(%)	-34.58	-43.16	-41.87	-44.36	-3.87
行业(%)	17.17	173.83	18.08	29.63	18.84

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2024-12-31","value":"67.18","vol":"13.73"},{"date":"2024-09-30","value":"-11.07","vol":"-54.03"},{"date":"2024-06-30","value":"-3.05","vol":"-10.70"},{"date":"2024-03-31","value":"-10.74","vol":"-527.00"},{"date":"2023-12-31","value":"-45.06","vol":"-34.06"}]

	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31
净利润同比增长率(%)	67.18	-11.07	-3.05	-10.74	-45.06
行业(%)	13.73	-54.03	-10.70	-527.00	-34.06

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 10/73 ， 11/73。

[{"date":"2024-12-31","value":"0.21","vol":"0.30"},{"date":"2024-09-30","value":"0.16","vol":"0.22"},{"date":"2024-06-30","value":"0.11","vol":"0.14"},{"date":"2024-03-31","value":"0.06","vol":"0.07"},{"date":"2023-12-31","value":"0.33","vol":"0.33"}]

	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31
总资产周转率(次)	0.21	0.16	0.11	0.06	0.33
行业(次)	0.30	0.22	0.14	0.07	0.33

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2024-12-31","value":"0.79","vol":"0.97"},{"date":"2024-09-30","value":"0.70","vol":"0.87"},{"date":"2024-06-30","value":"0.52","vol":"0.55"},{"date":"2024-03-31","value":"0.26","vol":"0.26"},{"date":"2023-12-31","value":"2.05","vol":"1.31"}]

	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31
存货增长率(次)	0.79	0.70	0.52	0.26	2.05
行业(次)	0.97	0.87	0.55	0.26	1.31

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 11/73 ， 7/73。

[{"date":"2024-12-31","value":"7.63","vol":"-14.06"},{"date":"2024-09-30","value":"14.53","vol":"-28.68"},{"date":"2024-06-30","value":"19.63","vol":"-36165.87"},{"date":"2024-03-31","value":"27.62","vol":"-43943.29"},{"date":"2023-12-31","value":"25.14","vol":"-170.98"}]

	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31
现金流量净额/营业收入	7.63	14.53	19.63	27.62	25.14
行业	-14.06	-28.68	-36165.87	-43943.29	-170.98

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2024-12-31","value":"1.69","vol":"2.10"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"0.99","vol":"2.73"},{"date":"2024-03-31","value":"","vol":"0.00"},{"date":"2023-12-31","value":"0.77","vol":"2.86"}]

	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31
资本支出／折旧和摊销	1.69	-	0.99	-	0.77
行业	2.10	0.00	2.73	0.00	2.86

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 12/73 ， 14/73。

[{"date":"2024-12-31","value":"6.74","vol":"4.96"},{"date":"2024-09-30","value":"12.01","vol":"7.11"},{"date":"2024-06-30","value":"13.08","vol":"6.99"},{"date":"2024-03-31","value":"14.08","vol":"8.01"},{"date":"2023-12-31","value":"14.08","vol":"7.53"}]

	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31
流动比率	6.74	12.01	13.08	14.08	14.08
行业	4.96	7.11	6.99	8.01	7.53

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2024-12-31","value":"5.39","vol":"3.96"},{"date":"2024-09-30","value":"10.84","vol":"5.73"},{"date":"2024-06-30","value":"11.94","vol":"5.87"},{"date":"2024-03-31","value":"12.86","vol":"6.87"},{"date":"2023-12-31","value":"12.85","vol":"6.45"}]

	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31
速动比率	5.39	10.84	11.94	12.86	12.85
行业	3.96	5.73	5.87	6.87	6.45

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 13/73 ， 13/73。

[{"date":"2024-12-31","value":"10.87","vol":"29.00"},{"date":"2024-09-30","value":"7.06","vol":"24.72"},{"date":"2024-06-30","value":"6.71","vol":"24.44"},{"date":"2024-03-31","value":"6.51","vol":"23.84"},{"date":"2023-12-31","value":"6.49","vol":"23.96"}]

	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31
资产负债率(%)	10.87	7.06	6.71	6.51	6.49
行业(%)	29.00	24.72	24.44	23.84	23.96

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2024-12-31","value":"0.12","vol":"0.59"},{"date":"2024-09-30","value":"0.08","vol":"0.40"},{"date":"2024-06-30","value":"0.07","vol":"0.38"},{"date":"2024-03-31","value":"0.07","vol":"0.36"},{"date":"2023-12-31","value":"0.07","vol":"0.35"}]

	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31
产权比率 (%)	0.12	0.08	0.07	0.07	0.07
行业(%)	0.59	0.40	0.38	0.36	0.35

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
华安证券	2025-03-31	买入
国联民生	2025-03-25	买入
中邮证券	2025-03-25	买入
华源证券	2025-03-24	买入
国投证券	2025-03-24	买入
广发证券	2025-03-24	买入

机构预测

机构预测该股2025年每股收益与前一年相同，长期投资价值一般。

[{"date":"2021","yellowRectValue":"3.45","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"4.32","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"2.37","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"3.97","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"5.57","blueLineValue":"1.11","type":"YC"}]

[博雅生物]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]